166 related articles for article (PubMed ID: 32665)
1. Evidence for altered cyclic nucleotide metabolism during compensatory renal hypertrophy and neonatal kidney growth.
Schlondorff D; Weber H
Yale J Biol Med; 1978; 51(3):387-92. PubMed ID: 32665
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide concentrations in relation to renal growth and hypertrophy.
Solomon S; Wise PM; Sanborn C; Ratner A
Yale J Biol Med; 1978; 51(3):373-9. PubMed ID: 216165
[TBL] [Abstract][Full Text] [Related]
3. Metabolic response to renal compensatory growth.
Lowenstein LM; Toback FG
Yale J Biol Med; 1978; 51(3):395-401. PubMed ID: 735159
[TBL] [Abstract][Full Text] [Related]
4. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
DeRubertis FR; Craven P
Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
[TBL] [Abstract][Full Text] [Related]
5. Increases of guanosine 3',5'-monophosphate-related enzymes in kidneys of developing rats.
Schlondorff D; Trizna W
Pediatr Res; 1978 Aug; 12(8):882-5. PubMed ID: 28509
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide metabolism in compensatory renal hypertrophy and neonatal kidney growth.
Schlondorff D; Weber H
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):524-8. PubMed ID: 1760
[TBL] [Abstract][Full Text] [Related]
7. [Metabolism of cGMP with K+ concentration increase in the medium causing depolarization of cortical cell membranes in normal and irradiated rats].
Skopenko EV; Bratus' NI; Parkhomets TI; Vasil'ev AN; Kucherenko NE
Ukr Biokhim Zh (1978); 1985; 57(2):76-9. PubMed ID: 2860748
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
9. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
10. [Changes in cyclic nucleotide metabolism in compensatory adrenal hypertrophy (following unilateral adrenalectomy)].
Iudaev NA; Afinogenova SA; Zhukova TV
Probl Endokrinol (Mosk); 1982; 28(6):59-66. PubMed ID: 6130520
[TBL] [Abstract][Full Text] [Related]
11. Tissue guanosine-3',5'-cyclic monophosphate levels and soluble guanylate cyclase activity: a positive correlation during unilateral cryptorchidism in the rat testis.
Spruill WA; Steiner AL; Earp HS
J Clin Invest; 1978 Sep; 62(3):568-76. PubMed ID: 29053
[TBL] [Abstract][Full Text] [Related]
12. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
13. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
Whalin ME; Scammell JG; Strada SJ; Thompson WJ
Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
[TBL] [Abstract][Full Text] [Related]
15. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.
Bai Y; Ye S; Mortazavi R; Campese V; Vaziri ND
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F974-80. PubMed ID: 17122386
[TBL] [Abstract][Full Text] [Related]
16. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
[TBL] [Abstract][Full Text] [Related]
17. Developmental appearance of pineal adrenergic-->guanosine 3',5'-monophosphate response is determined by a process down-stream from elevation of intracellular Ca2+: possible involvement of a diffusible factor.
White BH; Klein DC
Endocrinology; 1993 Mar; 132(3):1026-34. PubMed ID: 8095011
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of cyclic GMP content by cyclic GMP-phosphodiesterase and guanylate cyclase in SHR with CsA-induced nephrotoxicity.
Hosogai N; Seki J; Goto T
Br J Pharmacol; 2001 Nov; 134(5):995-1002. PubMed ID: 11682447
[TBL] [Abstract][Full Text] [Related]
19. The cGMP system in irradiated animals. Changes in cGMP content and activities of guanylate cyclase and cyclic nucleotide phosphodiesterase.
Sobolev AS; Tertov VV; Rybalkin SD
Acta Radiol Oncol; 1984; 23(5):367-73. PubMed ID: 6150603
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
